Zelira Therapeutics is headquartered in Perth, Australia.
Zelira Therapeutics disclosed revenue of 1M AUD for 2024 and 0M AUD for 2023.
Zelira Therapeutics is a life science company.
Zelira Therapeutics was founded in 2003.
101 St George's Terrace Level 3,
Perth,
6000
Australia,
+61 8 6558 0886
www.zeliratx.com
Zelira Therapeutics is a biopharmaceutical company developing proprietary cannabinoid formulations to treat a variety of medical conditions. Zelira Therapeutics is based in Perth, Australia.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | 1 | - | - | - | - | - | 1 |
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 1 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
